Morpholine and thiomorpholine tachykinin receptor antagonists

  • US 6,235,735 B1
  • Filed: 03/16/2000
  • Issued: 05/22/2001
  • Est. Priority Date: 06/29/1992
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for the prevention or treatment of nausea or emesis induced by radiation or by a cancer chemotherapeutic agent in a mammal in need thereof which comprises the administration to the mammal of an effective amount of a compound which is 2-(R)-(1-(R)-3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine, or a pharmaceutically acceptable salt thereof.

View all claims

    Thank you for your feedback